1,802 reports of this reaction
3.1% of all ABALOPARATIDE reports
#6 most reported adverse reaction
ARTHRALGIA is the #6 most commonly reported adverse reaction for ABALOPARATIDE, manufactured by Radius Health, Inc.. There are 1,802 FDA adverse event reports linking ABALOPARATIDE to ARTHRALGIA. This represents approximately 3.1% of all 58,437 adverse event reports for this drug.
Patients taking ABALOPARATIDE who experience arthralgia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ARTHRALGIA is moderately reported among ABALOPARATIDE users, representing a notable but not dominant share of adverse events.
In addition to arthralgia, the following adverse reactions have been reported for ABALOPARATIDE:
The following drugs have also been linked to arthralgia in FDA adverse event reports:
ARTHRALGIA has been reported as an adverse event in 1,802 FDA reports for ABALOPARATIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ARTHRALGIA accounts for approximately 3.1% of all adverse event reports for ABALOPARATIDE, making it a notable side effect.
If you experience arthralgia while taking ABALOPARATIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.